Search
Add filters:
Use filters to refine the search results.
Results 1-4 of 4 (Search time: 0.006 seconds).
- previous
- 1
- next
Item hits:
Issue Date | Title | Author(s) |
---|---|---|
2010 | Differential expression of mTOR signalling components in drug resistance in ovarian cancer | Foster, H; Coley, HM; Goumenou, A; Pados, G; Harvey, AJ; Karteris, E |
2014 | The human myometrium differentially expresses mTOR signalling components before and during pregnancy: Evidence for regulation by progesterone | Foster, HA; Davies, J; Pink, RC; Turkcigdem, S; Goumenou, A; Carter, DR; Saunders, NJ; Thomas, P; Karteris, E |
31-Oct-2018 | Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry | Rogers‑Broadway, KR; Kumar, J; Sisu, C; Wander, G; Mazey, E; Jeyaneethi, J; Pados, G; Tsolakidis, D; Klonos, E; Grunt, T; Hall, M; Chatterjee, J; Karteris, E |
21-Dec-2016 | Human C1q Induces Apoptosis in an Ovarian Cancer Cell Line via Tumor Necrosis Factor | Kaur, A; Sultan, SHA; Murugaiah, V; Pathan, AA; Alhamlan, F; Karteris, E; Kishore, U |
Discover
Subject